Steve Valenzuela - 27 Feb 2024 Form 4 Insider Report for Alarm.com Holdings, Inc. (ALRM)

Role
Chief Financial Officer
Signature
/s/ Daniel Ramos, Attorney-in-Fact
Issuer symbol
ALRM
Transactions as of
27 Feb 2024
Net transactions value
-$350,328
Form type
4
Filing time
29 Feb 2024, 20:05:00 UTC
Previous filing
16 Aug 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALRM Common Stock Options Exercise $258,562 +4,375 +12% $59.10 41,875 27 Feb 2024 Direct
transaction ALRM Common Stock Options Exercise $197,592 +5,208 +12% $37.94 47,083 27 Feb 2024 Direct
transaction ALRM Common Stock Sale $708,088 -9,583 -20% $73.89 37,500 27 Feb 2024 Direct F1
transaction ALRM Common Stock Options Exercise $96,562 +1,875 +5% $51.50 39,375 29 Feb 2024 Direct
transaction ALRM Common Stock Options Exercise $338,676 +5,208 +13% $65.03 44,583 29 Feb 2024 Direct
transaction ALRM Common Stock Sale $533,633 -7,083 -16% $75.34 37,500 29 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRM Stock Option (Right to Buy) Options Exercise $0 -4,375 -35% $0.000000 8,125 27 Feb 2024 Common Stock 4,375 $59.10 Direct F3
transaction ALRM Stock Option (Right to Buy) Options Exercise $0 -5,208 -64% $0.000000 2,917 27 Feb 2024 Common Stock 5,208 $37.94 Direct F4
transaction ALRM Stock Option (Right to Buy) Options Exercise $0 -1,875 -15% $0.000000 10,625 29 Feb 2024 Common Stock 1,875 $51.50 Direct F5
transaction ALRM Stock Option (Right to Buy) Options Exercise $0 -5,208 -93% $0.000000 417 29 Feb 2024 Common Stock 5,208 $65.03 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.68 - $74.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.02 - $75.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through May 1, 2027, subject to the Reporting Person's continued service with the Issuer through each such date.
F4 The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each such date.
F5 The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through May 1, 2028, subject to the Reporting Person's continued service with the Issuer through each such date.
F6 The shares underlying the option exercised in this transaction were fully vested and exercisable. The remainder of the shares underlying the option shall continue to vest and become exercisable ratably on a monthly basis on the first day of each month through April 1, 2024, subject to the Reporting Person's continued service with the Issuer through each such date.